<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>137 patients with severe aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> (SAA) were treated in Basel from 1976 to 1986 </plain></SENT>
<SENT sid="1" pm="."><plain>34 underwent bone marrow transplantation (BMT) and 103 received antilymphocyte globulin (ALG) therapy </plain></SENT>
<SENT sid="2" pm="."><plain>We have analysed the incidence of late haematological complications in both groups of patients </plain></SENT>
<SENT sid="3" pm="."><plain>20 patients treated with ALG developed a late haematological complication </plain></SENT>
<SENT sid="4" pm="."><plain>A <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> or frank <z:mpath ids='MPATH_336'>leukaemia</z:mpath> occurred in eight and <z:e sem="disease" ids="C0024790" disease_type="Disease or Syndrome" abbrv="PNH">paroxysmal nocturnal haemoglobinuria</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>) in 13 patients </plain></SENT>
<SENT sid="5" pm="."><plain>Nine of the 13 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> had clinical signs of haemolysis, four only had positive laboratory tests </plain></SENT>
<SENT sid="6" pm="."><plain>One patient had <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> and <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>The risk of developing a haematological complication increased continuously and reached 57% at 8 years </plain></SENT>
<SENT sid="8" pm="."><plain>Neither <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> nor <z:mpath ids='MPATH_336'>leukaemia</z:mpath> occurred in patients treated with BMT </plain></SENT>
<SENT sid="9" pm="."><plain>The increased survival rate and the long observation time after ALG therapy have revealed a new perspective of the prognosis of aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Patients treated with BMT appear to be cured whereas those treated with ALG remain at risk for late complications </plain></SENT>
</text></document>